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Abstract
Introduction. Atrial remodeling due to atrial fibrillation (AF) is characterized by electrical and structural changes of 
cardiomyocytes that are in response for arrhythmia self-perpetuation and resistance to sinus rhythm conversion. This 
project was designed to study nonlinear methods of heart rate variability (HRV) (such as approximate entropy of heart 
rate [ApEn]) that can best characterize LA structural and functional remodeling and its association with clinical course 
in patients with paroxysmal and persistent AF.
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Material and methods. Traditional time and frequency domain HRV indices were analyzed in 75 patients (mean age 55 
[49–62] years, 79% male) with paroxysmal or persistent AF on a background of ischemic heart disease (IHD) and/or 
hypertension without significant structural myocardial damage and in 19 control patients without AF (mean age 56 
[49–61] years, 63% male). Echocardiography was performed to assess size and function of left atrium (LA).
Results. In patients with paroxysmal or persistent AF the ApEn value was significantly lower than in the control patients 
group. Echo-parameters of LA, characterizing its structure and function, were correlated with ApEn value. The AF du-
ration was negatively correlated with the ApEn value. Its values less than 0.93 was associated with a larger LA size 
(> 39 mm) and more frequent AF.
Conclusions. There is a strong correlation of ApEn value and atrial remodeling. ApEn values less than 0.93 are related 
to AF recurrence and can be considered as prognostic risk factor of structural and functional remodeling of the heart 
muscle in patients with AF.
Key words: atrial fibrillation, left atrium, echocardiography, structural and functional remodeling, heart rate variability, 
nonlinear analyses, approximate entropy.
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ures of entropy, such as sample entropy (SampEn) and 
approximate entropy (ApEn), together with the detrended 
fluctuation analysis (DFA) have been applied to study the 
HRV complexity evolution in the minutes preceding spon-
taneous paroxysmal AF onset. ApEn provides a measure 
of the degree of irregularity or randomness within a series 
of data [12]. ApEn is a family of statistics that addresses 
the question, given a sequence of two (or three or four) 
interbeat intervals, what is the probability that the next 
consecutive interval falls within a predetermined range. 
Thus, ApEn is a measure of short-range correlation. ApEn, 
in general, represents the information contained in a time 
series. A low value indicates that the signal is deterministic; 
a high value indicates randomness [13].
This nonlinear index of HR dynamics has provided in-
formation on the vulnerability to AF [14]. As for structural 
remodeling, it has been shown that atrial fibrosis in the 
setting of AF is the result of a complex interactive effect 
among profibrotic signaling pathways, inflammation and 
oxidative stress, the first two contributors being extensively 
studied [15].
Nevertheless, based on the available data it is not stip-
ulated whether there is an association between ApEn value 
and atrial remodeling, and its correlation with AF duration.
The aims of this study was to establish the relationship 
of nonlinear index of HRV, such as ApEn, with echocardio-
graphic parameters of left atrium (LA) and AF clinical course 
in patients with paroxysmal and persistent AF.
Materials and methods
A total of 75 patients with AF admitted to the Arrhythmology 
Department of the Grodno Regional Clinical Cardiology Cen-
tre (Belarus) due to AF have been recruited into the study.
Introduction
Atrial fibrillation (AF) is the most common cardiac arrhyth-
mia, affecting approximately 1% of the general population 
and up to 8% of subjects over the age of 80 years [1]. AF 
is a major contributor to cardiovascular mortality and mor-
bidity, associated with decreased quality of life, increased 
incidence of congestive heart failure, embolic phenomena, 
including stroke, and a 30% higher risk of death [2–4].
AF is more prominent in the context of alterations in 
atrial tissue properties — due to disease, arrhythmias, 
or age — known as remodeling. In fact, AF itself leads to 
remodeling, causing electrophysiological (“electrical”), 
contractile, and structural changes [5]. Although AF can 
typically be reversed in its early stages, it becomes more 
difficult to eliminate over time due to such remodeling — 
hence the expression “AF begets AF” [6].
The atrial chambers may have substantial geometric 
remodeling (chamber remodeling) during evolving AF [7]. 
Predictably, structural remodeling will be more difficult to 
reverse as compared to the electrical one [8].
Autonomic modulation and AF
Many factors related to the autonomic nervous system 
can influence AF [9]. Heart rate variability (HRV) analysis 
has been used extensively in the study of atrial fibrillation. 
These observations suggest that the mechanisms involved 
in cardiovascular regulation can interact with each other 
in a nonlinear way, so HR time series analysis by nonlinear 
metrics has recently gained great interest [10]. Further-
more, chaotic behavior can be interpreted in the diseased 
heart with atrial fibrillation (AF) at cellular level and atrial 
electrophysiological remodeling during this arrhythmia 
is a far-from-linear process [11]. Thereby, several meas-
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These patients included 48 subjects with paroxysmal AF 
and 27 subjects with persistent AF, with the background of 
ischemic heart disease and/or arterial hypertension, with-
out significant structural myocardial damage. Persistent AF 
was defined as AF which is sustained beyond seven days, 
or lasting less than seven days but necessitating phar-
macological or electrical cardioversion. The study control 
group included 19 patients with no history of AF. All study 
participants had background history of coronary artery 
disease and/or hypertension. Patients with thyroid dys-
function, acute stroke, acute myocardial infarction, acute 
myocarditis, known chronic heart failure (NYHA ≥ 2) and 
higher, diabetes, severe chronic diseases (e.g., severe renal 
or liver failure) or pregnancy were excluded from the study.
Routine laboratory and physical examinations were 
used to exclude cardiovascular diseases.
All patients underwent instrumental and laboratory study 
after signing an informed consent form that was approved by 
our institution’s committee on human investigation.
On the admission AF patients were subjected to phar-
macological or direct current cardioversion. In all patients 
with persistent atrial fibrillation, cardioversion was per-
formed with a transthoracic electrical shock of 200 to 
360 J. None of patients have been performed radiofre-
quency catheter ablation. All patients were successfully 
cardioverted and remained in sinus rhythm at discharge. 
So all of our patients were examined on sinus rhythm.
Heart rate variability
To assess the functional state we used a standardized 
5-min analysis of HR after an overnight fast. Patients stop 
taking drugs in 2 days before the study. The RR intervals 
were recorded in the supine position with an HR monitor 
of QRS complexes “Intekard” (“Intekard”, Belarus) and 
software for it “Breeze XP” [13]. A series of 250 beats was 
selected to analyze nonlinear parameter, such as ApEn. 
Additionally, standard HRV measures were determined: 
time domain (SDNN, pNN50, rMSSD) and frequency do-
main methods (by four components: total-frequency (TF) 
component (0.01 to 0.5 Hz), low-frequency (LF) component 
(0.04 to 0.15 Hz), very low-frequency (VLF) component 
(below 0.04 Hz) and high-frequency (HF) component (0.15 
to 0.5 Hz). Two component ratio (LF/HF) expressing the 
sympathovagal balance was also calculated.
Echocardiography
Two-dimensional transthoracic echocardiography was 
performed using Philips IE-33 system and broadband 
phased array probe (S5-1, 1–5 MHz, Philips, USA) The 
following parameters were obtained: left atrial systolic 
diameter (LASD), LV end-systolic diameter (LVESD), LV 
end-diastolic diameter (LVEDD), LV mass (LVM) and LV 
mass index (LVMI) [16].
In addition to standard echocardiographic parameters, 
left atrial (LA) geometry and function was assessment by 
measurement of LA volume, LA volume index, LV stroke 
volume, LA ejection fraction using bi-plane area-length 
method as reported previously [17–19].
Statistical analysis
Normally distributed data are presented as mean ± 
standard deviation and non-normally distributed data are 
reported as median and interquartile range. To non-normal 
distribution of data, multiple comparisons among three 
groups were conducted by Kruskal-Wallis H test and differ-
ences between two groups were assessed by Mann-Whit-
ney U test for post hoc analysis. Proportional data were 
compared with a chi square test. A one way ANOVA test 
was used for assessing the statistical significance where 
appropriate. To identify the relationship between indicators 
of an abnormal distribution the Spearman rank correlation 
coefficient (rs) was used, and the Student’s test for the 
normal distribution of the sign. Correlation between ApEn 
value and AF duration was examined by simple logistic 
regression. In assessing the significance of differences in 
the frequency of quality indicators the two-sided Fisher’s 
exact test was used. General Classification Regression 
Tree Models Analyze was used to determine an affecting 
of some indicators on other variables, their hierarchy of 
influence, thereby defining its prognostic significance [14]. 
The differences were considered statistically significant 
when p < 0.05 (2-tailed). The analysis was performed using 
Statistica 6.0 software package (Statsoft, US).
Results
There was no significant difference in age, gender, renal 
function, history of coronary artery disease and hyperten-
sion between the studied patients groups (Table 1).
Table 2 shows medications used for pharmacological 
cardioversion and after direct current cardioversion, where-
as Table 3 shows echocardiographic parameters.
The analysis has shown that the ApEn level in the con-
trol group was 1.03 (0.94–1.10), that was significantly (p < 
0.05) higher than in groups 1 and 2 — 0.09 (0.007–0.96) 
and 0.02 (0.003–0.88), respectively, while no statistically 
significant differences between the two groups of patients 
— with paroxysmal and persistent AF — have been revealed 
(Table 4).
Further analysis revealed significant correlation be-
tween the ApEn value and echocardiographic parameters of 
LA in patients of all groups: LA systolic diameter (R = –0.24, 
p = 0.043), LA systolic volume (R = –0.30, p = 0.040), 
the LA ejection fraction (R = 0.36, p = 0.013). Logistic 
regression revealed a significant associations between the 
AF duration and the ApEn value (B = –0.31, p = 0.028).
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On the next step we used General Regression Tree Model 
Classification as a prediction model that can be re presented 
as a decision tree [14]. The ApEn value < 0.93 was asso-
ciated with a larger LA size (> 39 mm) (Figure 1).
Then all three patients groups (n = 75) were divided 
into groups according to the level of ApEn (0.93) (Table 5).
Table 1. Characteristics of the studied patients groups
Patients characteristics Paroxysmal AF 
(n = 48)
Persistent AF 
(n = 27)
Controls 
(n = 19)
p value 
(by Kruskal-Wallis H test)
Age [years] 56 (50–64) 53 (46–61) 56 (49–61) 0.72
Male gender, n [%] 37 (77) 22 (81) 12 (63) 0.91
Hypertension, n [%] 39 (81) 22 (81) 17 (89) 0.99
Coronary artery disease, n [%] 41 (85) 21 (78) 14 (74) 0.49
eGFR [ml/min/1.73 m2] 68 ± 13 66 ± 13 72 ± 18 0.74
AF — atrial fibrillation; eGFR — estimated glomerular filtration rate
Table 2. Medications used for pharmacological cardioversion (Group 1) and after direct current cardioversion (Group 2)
Medications Paroxysmal AF 
(n = 48)
Persistent AF 
(n = 27)
p value 
(by Kruskal-Wallis H test)
Beta-blocker, n [%] 12 (25) 13 (48.1) 0.07
Amiodarone, n [%] 20 (41.7) 12 (44.4) 1.0
Sotalol, n [%] 9 (18.8) 1 (3.7) 0.08
Aethacizin, n [%] 7 (14.6) 1 (3.7) 0.25
Warfarin, n [%] 23 (47.9) 27 (100) < 0.0001
AF — atrial fibrillation
Table 3. Echocardiographic parameters
Paroxysmal AF 
(n = 48)
Persistent AF 
(n = 27)
Control 
(n = 19)
p value (by Kruskal-Wallis 
H test)
Left atrial parameters
Systolic diameter, mm 38 ± 3* 41 ± 4*# 36 ± 2 0.0015
Stroke volume, ml 35 ± 10 30 ± 9 35 ± 10 0.15
Diastolic volume [ml] 70 ± 16 78 ± 18* 61 ± 18 0.10
Systolic volume [ml] 34 ± 14 47 ± 18*# 26 ± 9 0.0008
Systolic volume index, [ml/m2] 16 ± 6 24 ± 10*# 13 ± 4 0.0005
Diastolic volume index, ml/m2 34 ± 7 39 ± 10 31 ± 8 0.08
Ejection fraction [%] 52 ± 11 37 ± 11*# 58 ± 7 0.0001
Left ventricular parameters
Mass index [g/m2] 118 ± 25 119 ± 22 105 ± 14 0.23
End-diastolic volume [ml] 128 ± 20 131 ± 29 121 ± 26 0.44
End-systolic volume [ml] 42 ± 10 52 ± 23* 37 ± 9 0.06
Stroke volume [ml] 84 ± 14 79 ± 14 81 ± 17 0.22
Ejection fraction [%] 66 ± 5 61 ± 8*# 68 ± 5 0.0027
*Significant differences compared with control group; #significant differences compared with group 1 (by Mann-Whitney U test); AF — atrial fibrillation
In the group with the ApEn value greater than 0.93 the 
percentage of patients without AF episodes was signifi-
cantly higher (p = 0.0008), while the ApEn value less than 
0.93 was associated with a new-onset AF (p = 0.02). AF 
recurrences were significantly more frequent if ApEn value 
was less than 0.93 (p = 0.0045), while its higher values 
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Table 4. Heart rate variability parameters
Parameter Group 1 
Paroxysmal AF 
(n = 48)
Group 2 
Persistent AF 
(n = 27)
Group 3 
Control 
(n = 19)
p value  
(by Kruskal-Wallis 
H test)
SDNN [ms] 36.1 (25.6; 69.4) 41.3 (27.0; 51.3) 32.4 (26.4; 50.9) 0.58
rMSSD [ms] 27.3 (16.6; 55.6) 29.75 (17.3; 53.8) 27.95 (20.7; 44.7) 0.82
NN50 3.0 (0.000; 13.0) 4.0 (0.5; 10.5) 2.5 (1.0; 5.0) 0.74
pNN50 [%] 1.0 (0.000; 4.6) 1.3 (0.15; 4.1) 0.75 (0.3; 1.3) 0.58
HF [%] 51.3 (41.4; 61.5) 50.1 (42.65; 55.85) 41.75 (38.1; 52) 0.58
LF [%] 33.50 (28; 39.5) 34.35 (28.3; 38.95) 36.15 (31.60; 42.10) 0.81
VLF [%] 15.20 (9.00; 19.30) 15.55 (11.35; 19.95) 17.10 (14.40; 22.20) 0.28
LF/HF 0.65 (0.64; 0.68) 0.69 (0.66; 0.70) 0.87 (0.83; 0.81) 0.21
ApEn 0.09 (0.007; 0.96)* 0.02 (0.003; 0.88)* 1.03 (0.94; 1.10) 0.0098
HF [ms2] 328.1 (294.8; 590.9) 811.8 (246.4; 1026.3) 510.4 (321.1; 666.0) 0.22
LF [ms2] 303.6 (250.0; 420.7) 530.1 (245.9; 860.5) 299.7 (259.2; 480.2) 0.38
VLF [ms2] 149.3 (131.2; 176.1) 255.5 (107.3; 313.4) 160.7 (117.6; 268.1) 0.71
TP [ms2] 1210.50 (766.40; 2430.70) 1125.25 (788.0; 2018.55) 1021.15 (659.5; 1444.9) 0.58
*Significant differences compared with the control group (p < 0.05) (by Mann-Whitney U test); AF — atrial fibrillation; SDNN — standard deviation of normal-to-normal R-R intervals; rMSSD — the root mean 
square of successive differences; NN50 — count, defined as the mean number of times per hour in which the change in consecutive normal sinus (NN) intervals exceeds 50 ms; pNN50 = (NN50 count)/ 
/(total NN count) — the fraction of consecutive NN intervals that differ by more than 50 ms; LF — low-frequency; VLF — very low-frequency; ApEn — approximate entropy; TP — total power
Figure 1. Classification for the left atrial according to approximate entropy (ApEn) value; LA — left atrium; M — mean value; D — a dispersion 
of the sample
M = 37.9
D = 13.1
General classification/regression tree for LA [mm]
n = 64
M = 39.3 
D = 13.0 
n = 38
M = 36.2
D = 8.28
n = 26
M = 38.4 
D = 9.6 
n = 34
M = 44.3
D = 11.2
n = 4
ApEn
 0.928 > 0.928
ApEn
 0.86 > 0.86
cardium that contributes to the persistence of arrhythmia 
[20, 21]. Several reports have indicated that duration of AF 
is associated with the major changes in cardiac electrical 
properties that may favor arrhythmia recurrence. Structural 
remodeling has also been considered as a critical pro-ar-
rhythmic factor [22]. Less emphasis has been attributed to 
the possible role of the autonomic nervous system. In the 
past, the term vagal or sympathetic AF [9] has been used 
to characterize the autonomic environment in which AF has 
were associated with no AF recurrence during a year (Ta-
ble 6). As we can see from the table, the sensitivity of this 
detection is about 70% and specificity — 66%.
Discussion
The studies show that persistent or recurrent AF is constant-
ly associated with the phenomenon of atrial remodeling 
characterized by electrical and structural changes of myo-
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been reported to occur. No attention was instead directed 
to the possibility that a specific autonomic pattern could 
facilitate AF recurrence after electrical or pharmacological 
cardioversion.
The mechanisms leading to the initiation of AF have 
been extensively investigated for the last decade. It has 
been proposed that the autonomic nervous system might 
have a role in the initiation of this arrhythmia. Precisely, 
increased vagal tone can predispose to the development 
of AF [23].
Vagal mechanisms have been indicated to be pre-
dominant when AF onset occurred after meals or during 
nighttime in absence of significant increases in heart rate, 
particularly in male patients without evidence of organic 
heart disease. In contrast, a pro-arrhythmic role of sym-
pathetic activation was suspected when AF was initiated 
during exercise, emotion, or isoproterenol infusion. How-
ever, in most instances, recognition of a specific autonomic 
pattern is difficult; also, when HRV analysis was used to 
characterize the role of the autonomic nervous system 
before AF onset, contrasting results were noticed [24]. The 
complexity of the problem might be partially explained by 
the fact that both sympathetic and vagal activation may 
exert a pro-arrhythmic action by affecting atrial action 
potential duration and conduction velocity [25, 26]; non-
uniform autonomic innervation of the atria may also play 
a critical role [27].
ApEn assigns a non-negative number to a sequence 
or time series, with larger values corresponding to greater 
process randomness or serial irregularity, and smaller 
values corresponding to more instances of recognizable 
features or patterns in the data [12]. ApEn measures the 
logarithmic likelihood that runs of patterns that are close 
(within a tolerance window r) for length m continuous 
observations remain close (within the same tolerance r) 
on next incremental comparison. The input variables m 
and r must be fixed to calculate ApEn. The method can be 
applied to relatively short time series, but the amounts of 
data points influence the value of ApEn [28].
Our data indicate the existence of correlation between 
the ApEn value and LA parameters characterizing its struc-
tural and functional state. Being associated with AF clinical 
course these indicators let us to suggest that the ApEn 
value less than 0.93 can be prognostic risk factor of both 
AF recurrence and structural changes in the LA.
Conclusions
1. In patients with paroxysmal or persistent AF with arterial 
hypertension and/or coronary artery disease the ApEn val-
ue was significantly lower, than in the control group. 2. The 
ApEn value was associated with the parameters of left 
atrium that characterize its structure and function. 3. The 
AF duration was negatively correlated with ApEn value. 
4. The ApEn value less than 0.93 was associated with 
a larger LA size and AF recurrence, while the percentage 
of patients without AF episodes was significantly higher 
when ApEn value was greater than 0.93.
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Table 5. The association of approximate entropy (ApEn) value and atrial fibrillation (AF) frequency
AF frequency ApEn < 0.93 
(n = 43)
ApEn > 0.93 
(n = 32)
p value
n % n %
Without AF 4 9 14 44 0.0008*
New-onset AF 12 28 2 6 0.02*
Up to 1 per year 5 12 5 16 NS
1 per 3–6 months 8 19 3 9 NS
More than 1 per month 14 32 8 25 NS
NS — non-significant
Table 6. The relationship of approximate entropy (ApEn) value and atrial fibrillation (AF) recurrence
AF recurrence ApEn < 0.93 
(n = 43)
ApEn > 0.93 
(n = 32)
p
n % n %
No AF recurrences 13 30 21 66 0.0045*
AF recurrences 30 70 11 34 0.0045*
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Streszczenie
Wstęp. Remodeling przedsionków spowodowany migotaniem przedsionków (AF) charakteryzuje się elektrycznymi 
i strukturalnymi zmianami kardiomiocytów w odpowiedzi na utrwaloną arytmię i oporność na leczenie mające na celu 
przywrócenie rytmu zatokowego. Celem tego projektu było zbadanie nieliniowych metod oceny zmienności rytmu serca 
(HRV) (np. entropia aproksymacji rytmu serca [ApEn]), które najlepiej charakteryzują strukturalny i funkcjonalny remo-
deling lewego przedsionka (LA) i jego związek z przebiegiem klinicznym u chorych z napadowym i przetrwałym AF.
Materiał i metody. Przeanalizowano tradycyjne wskaźniki czasowe i częstotliwościowe HRV w grupie 75 chorych (śred-
nia wieku 55 [49–62] lat, 79% mężczyzn) z napadowym lub przetrwałym AF na podłożu choroby niedokrwiennej serca 
i/lub nadciśnienia tętniczego bez istotnych strukturalnych uszkodzeń miokardium oraz w grupie kontrolnej złożonej z 19 
osób bez AF (średnia wieku 56 [49–61] lat, 63% mężczyzn). Przeprowadzono również badanie echokardiograficzne 
w celu oceny wielkości i czynności LA.
Wyniki. U chorych z napadowym lub przetrwałym AF wartość ApEn była istotnie niższa niż w grupie kontrolnej. Parametry 
echokardiograficzne LA, charakteryzujące jego strukturę i czynność, były skorelowane z wartością ApEn. Stwierdzono 
ujemną korelację między czasem trwania AF a wartością ApEn. Wartości ApEn mniejsze niż 0,93 wiązały się z większym 
rozmiarem LA (> 39 mm) i częstszym AF.
Wnioski. Istnieje silna korelacja między wartością ApEn a remodelingiem przedsionka. Wartości ApEn mniejsze niż 0,93 
wiążą się z nawrotami AF i mogą służyć jako prognostyczny czynnik ryzyka strukturalnego i czynnościowego remodeling 
mięśnia sercowego u chorych z AF.
Słowa kluczowe: migotanie przedsionków, lewy przedsionek, echokardiografia, remodeling strukturalny i czynnościowy, 
zmienność rytmu serca, analizy nieliniowe, entropia aproksymacji
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